Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 13, 2023. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report discloses the closing of a previously announced registered direct offering priced at-the-market under Nasdaq rules.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a capital raising event rather than a comprehensive financial statement. No financial metrics are disclosed within the body of this 8-K.
Material Changes
- Capital Raise Completion: The Company closed a registered direct offering priced at-the-market.
- Regulatory Disclosure: The event was disclosed pursuant to Item 7.01 (Regulation FD Disclosure) and includes a press release as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors related to the offering terms. The Company explicitly states it undertakes no obligation to update, supplement, or amend the attached press release materials. The information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Verify the exact number of shares sold and the total gross proceeds raised by reviewing Exhibit 99.1 (Press Release dated November 13, 2023), as these figures are not in the 8-K text.
- Confirm the specific pricing mechanism and any underwriting discounts or commissions associated with the at-the-market offering.
- Check the Company's latest 10-Q or 10-K for current cash position and liquidity status, as this 8-K does not report balance sheet data.
- Review the press release for any use of proceeds disclosures or changes in the Company's capital structure.